What You Should Know:
- Eli Lilly and Company has announced positive topline results from its Phase 3 ATTAIN-2 trial, which evaluated orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight and type 2 diabetes.
- All three doses of the drug met the primary and all key secondary endpoints, showing significant weight loss, meaningful A1C reductions, and improvements in cardiometabolic risk factors over 72 weeks.
Significant Weight Loss and
Read More
Carna Health & Siemens Healthineers Partner to Advance AI-Powered CKD Screening
What You Should Know:
- Carna Health, a digital health company focused on kidney care, has announced a strategic agreement with Siemens Healthineers. The collaboration aims to accelerate the adoption of Carna's AI-enabled chronic kidney disease (CKD) platform and bring point-of-care testing systems to emerging markets.
- This will help improve early detection and CKD management for high-risk and underserved populations by integrating Carna Health’s digital platforms with Siemens
Read More
American Heart Association Launches Virtual Care Program to Reduce Heart Failure Readmissions
What You Should Know:
- With chronic disease rates rising and nearly one in four heart failure patients readmitted to the hospital within 30 days of discharge, healthcare systems face ongoing challenges in reducing hospital stays and readmissions. To address this critical gap, the American Heart Association has launched American Heart Association Connected Care™, Powered by Cadence. This new virtual care program delivers ongoing heart and cardiometabolic care to patients at home after their
Read More
Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights
What You Should Know:
- Mira, a hormonal health company, has launched Ultra4™, the first at-home hormone monitor to provide lab-quality insights.
- The new device tracks four key hormones—FSH, LH, E3G, and PdG—with a single wand and a 16-minute test. For the first time, people can monitor their entire cycle from home, from ovulation strength to hormonal balance, with the same precision previously available only in clinics.
Why Tracking Four Hormones Matters
Ultra4™'s technology
Read More
Sonio Launches New AI-Powered Product Suite to Enhance Maternal Healthcare in the U.S.
What You Should Know:
- Sonio, a MedTech company specializing in women’s and children’s health, has announced a new range of product offerings designed to serve the maternal community across the U.S..
- The new product offerings, which include Sonio Start, Sonio Plus, Sonio Premium, and Sonio Enterprise, are designed to meet the different needs of clinics and health systems at every level of care.
Addressing Inefficiencies with AI and Automation
The new offerings were specifically
Read More
United We Care and Mason County Launch Digital Mental Health Pilot
What You Should Know:
- United We Care, a global deep-tech mental health company, has partnered with Mason County, Washington, to successfully launch a digital mental health pilot program in one of the nation's mental health care deserts. The initiative provides residents with 24/7 confidential access to mental health and substance use support.
- The program has shown promising early results: 50% of users booked a session with a licensed mental health provider, 72.5% completed
Read More
Charlie Health Expands Virtual Behavioral Healthcare to Ages 8-64
What You Should Know:
- Charlie Health, a provider of virtual high-acuity behavioral healthcare, has announced a major expansion of its services to include individuals ages 8 to 64. With this change, Charlie Health is directly addressing critical care gaps for younger children and midlife adults, reinforcing its position as the only provider to offer this level of care to such a broad age range at scale.
- Access to high-acuity behavioral healthcare is more critical than ever,
Read More
PathAI and Moffitt Cancer Center Partner to Deploy AI Digital Pathology Platform, AISight® Dx
What You Should Know:
- PathAI, a provider of AI and digital pathology solutions, and Moffitt Cancer Center, a top cancer hospital, have announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight® Dx, across Moffitt’s pathology programs. The partnership aims to transform cancer detection and research through the use of AI.
AISight® Dx: Cloud-Native Digital Pathology
AISight® Dx is a cloud-native digital pathology image management
Read More
HHS Terminates California’s PREP Grant Over Refusal to Remove Gender Ideology Content
What You Should Know:
- The U.S. Department of Health and Human Services (HHS), through its Administration for Children and Families (ACF), has terminated California’s Personal Responsibility Education Program (PREP) grant.
-The termination follows California’s refusal to remove "radical gender ideology" from the federally funded education program, which is designed to prevent teenage pregnancy and sexually transmitted infections.
Rejecting Mandate to Change Sex-Ed
Read More
J.D. Power Study: Medicare Advantage Member Satisfaction Declines Amid Policy Changes
What You Should Know:
- A new report from J.D. Power reveals a significant decline in member satisfaction with Medicare Advantage (MA) plans. The J.D. Power 2025 U.S. Medicare Advantage Study reveals that satisfaction dropped to an average score of 623 out of 1,000, which is down 29 points from the previous year.
- According to the study, the primary cause for this decline is a 39-point drop in members' overall trust in their plans. This trend is occurring in the wake of significant
Read More
